Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

  • Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
    Aaron P. Jansen, Corinne E. Camalier, Cristi Stark and Nancy H. Colburn
    Mol Cancer Ther February 1 2004 3 (2) 103-110;

Article

  • Article
    Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts
    Maria Rosa Bani, Maria Ines Nicoletti, Nawal W. Alkharouf, Carmen Ghilardi, David Petersen, Eugenio Erba, Edward A. Sausville, Edison T. Liu and Raffaella Giavazzi
    Mol Cancer Ther February 1 2004 3 (2) 111-121;

  • Article
    Dual repair modulation reverses Temozolomide resistance in vitro
    Vincent A. Barvaux, Malcolm Ranson, Robert Brown, R. Stanley McElhinney, T. Brian H. McMurry and Geoffrey P. Margison
    Mol Cancer Ther February 1 2004 3 (2) 123-127;

  • Article
    Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo
    Nathalie Laurent, Sophie de Boüard, Jean-Sébastien Guillamo, Christo Christov, Roland Zini, Hélène Jouault, Patrice Andre, Vincent Lotteau and Marc Peschanski
    Mol Cancer Ther February 1 2004 3 (2) 129-136;

  • Article
    Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease
    Koji Kawakami, Mariko Kawakami and Raj K. Puri
    Mol Cancer Ther February 1 2004 3 (2) 137-147;

  • Article
    Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro
    Shane K. Green, Giulio Francia, Ciro Isidoro and Robert S. Kerbel
    Mol Cancer Ther February 1 2004 3 (2) 149-159;

  • Article
    Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles
    Sofia K. Gruvberger-Saal, Patrik Edén, Markus Ringnér, Bo Baldetorp, Gunilla Chebil, Åke Borg, Mårten Fernö, Carsten Peterson and Paul S. Meltzer
    Mol Cancer Ther February 1 2004 3 (2) 161-168;

  • Article
    Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect
    Richard L. Hayward, Janet S. Macpherson, Jeff Cummings, Brett P. Monia, John F. Smyth and Duncan I. Jodrell
    Mol Cancer Ther February 1 2004 3 (2) 169-178;

  • Article
    R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways
    Darrin M. Beaupre, Enrique Cepero, Esther A. Obeng, Lawrence H. Boise and Mathias G. Lichtenheld
    Mol Cancer Ther February 1 2004 3 (2) 179-186;

  • Article
    Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways
    Xu Dong Zhang, Susan K. Gillespie and Peter Hersey
    Mol Cancer Ther February 1 2004 3 (2) 187-197;

  • Article
    Differential effect of cadmium on cholinephosphotransferase activity in normal and cancerous human mammary epithelial cell lines
    Somdutta Sinha Roy, Shyamali Mukherjee, Sutapa Mukhopadhyay and Salil K. Das
    Mol Cancer Ther February 1 2004 3 (2) 199-204;

  • Article
    AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1
    Jason Savell, Yihong Ma, Kristin S. Morrow, Richard Jove, Nancy Olashaw, Pope L. Moseley, W. Douglas Cress and Walker Wharton
    Mol Cancer Ther February 1 2004 3 (2) 205-213;

  • Article
    Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: Novel strategies for colon cancer prevention and treatment
    Malisetty V. Swamy, Indranie Cooma, Jagan M.R. Patlolla, Barbara Simi, Bandaru S. Reddy and Chinthalapally V. Rao
    Mol Cancer Ther February 1 2004 3 (2) 215-221;

Back to top
PreviousNext
Molecular Cancer Therapeutics: 3 (2)
February 2004
Volume 3, Issue 2
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts

Jump to

  • Article
Advertisement
  • Most Cited
  • Most Read
Loading
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • Truncated BRCA2 Contributes to PARPi Resistance
  • ERPAS to Predict Response to Endocrine Therapy
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Sialoglycan mAb for Cancer Immunotherapy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement